Trial Profile
Phase II study of S-1 concurrent radiotherapy for locally advanced pancreatic cancer after induced chemoradiotherapy
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Apr 2016
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 28 Feb 2013 New trial record